{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:19Z","timestamp":1786980559016,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10198-019-01068-9","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T03:04:27Z","timestamp":1557975867000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1238-7156","authenticated-orcid":false,"given":"Valentina","family":"Prevolnik Rupel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9595-0954","authenticated-orcid":false,"given":"Marko","family":"Divjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1992-6087","authenticated-orcid":false,"given":"Zsombor","family":"Zrubka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9674-620X","authenticated-orcid":false,"given":"Fanni","family":"Rencz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9285-8746","authenticated-orcid":false,"given":"L\u00e1szl\u00f3","family":"Gul\u00e1csi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7741-4760","authenticated-orcid":false,"given":"Dominik","family":"Golicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6294-3256","authenticated-orcid":false,"given":"Dagmara","family":"Mirowska-Guzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9279-8627","authenticated-orcid":false,"given":"Judit","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6095-2295","authenticated-orcid":false,"given":"Valentin","family":"Brodszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2899-8557","authenticated-orcid":false,"given":"Petra","family":"Baji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9802-6545","authenticated-orcid":false,"given":"Jakub","family":"Z\u00e1vada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-5138","authenticated-orcid":false,"given":"Guenka","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-7093","authenticated-orcid":false,"given":"Alexandru","family":"Rotar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9636-6012","authenticated-orcid":false,"given":"M\u00e1rta","family":"P\u00e9ntek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"key":"1068_CR1","doi-asserted-by":"crossref","unstructured":"Ferrans, C.E.: Definitions and conceptual models of quality of life. In: Lipscomb J, Gotay C.C., Snyder C. (eds.) Outcomes assessment in cancer: Measures, methods, and applications, pp 14\u201313. Cambridge University Press, New York (2005)","DOI":"10.1017\/CBO9780511545856.002"},{"issue":"1","key":"1068_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1212\/WNL.53.1.162","volume":"53","author":"NK Leidy","year":"1999","unstructured":"Leidy, N.K., Elixhauser, A., Vickrey, B., Means, E., Willian, M.K.: Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 53(1), 162\u2013166 (1999)","journal-title":"Neurology"},{"issue":"Suppl 2","key":"1068_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/ene.12801","volume":"22","author":"AP Lysandropoulos","year":"2015","unstructured":"Lysandropoulos, A.P., Havrdova, E.: ParadigMS Group: \"Hidden\" factors influencing quality of life in patients with multiple sclerosis. Eur J Neurol 22(Suppl 2), 28\u201333 (2015)","journal-title":"Eur J Neurol"},{"issue":"4","key":"1068_CR4","first-page":"375","volume":"5","author":"J Opara","year":"2012","unstructured":"Opara, J., Brola, W., Leonardi, M., B\u0142aszczyk, B.: Quality of life in Parkinson`s disease. J Med Life 5(4), 375\u2013381 (2012)","journal-title":"J Med Life"},{"issue":"4 Suppl","key":"1068_CR5","first-page":"131","volume":"33","author":"C Bombardier","year":"1995","unstructured":"Bombardier, C., Melfi, C.A., Paul, J., et al.: Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgery. Med Care 33(4 Suppl), 131\u2013144 (1995)","journal-title":"Med Care"},{"key":"1068_CR6","volume-title":"Multiple Sclerosis Quality of Life Inventory: A user's manual","author":"PG Ritvo","year":"1997","unstructured":"Ritvo, P.G., Fischer, J.S., Miller, D.M., Andrews, H., Paty, D.W., LaRocca, N.G.: Multiple Sclerosis Quality of Life Inventory: A user's manual. National Multiple Sclerosis Society, New York (1997)"},{"issue":"3","key":"1068_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02260863","volume":"4","author":"V Peto","year":"1995","unstructured":"Peto, V., Jenkinson, C., Fitzpatrick, R., Greenhall, R.: The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 4(3), 241\u2013248 (1995)","journal-title":"Qual Life Res"},{"issue":"2\u20133","key":"1068_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000075783","volume":"17","author":"D Buck","year":"2004","unstructured":"Buck, D., Jacoby, A., Massey, A., Steen, N., Sharma, A., Ford, G.A.: Development and validation of NEWSQOL, the Newcastle Stroke-Specific Quality of Life Measure. Cerebrovasc Dis 17(2\u20133), 143\u2013152 (2004)","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"1068_CR9","first-page":"173","volume":"3","author":"S Pietersma","year":"2013","unstructured":"Pietersma, S., Van Den, A., Van Marle, M.E., de Vries, M.: Generic quality of life utility measures in health-care research: Conceptual issues highlighted for the most commonly used utility measures. Int J Wellbeing 3(2), 173\u2013181 (2013)","journal-title":"Int J Wellbeing"},{"issue":"5","key":"1068_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin, R., deCharro, F.: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33(5), 337\u2013343 (2001)","journal-title":"Ann Med"},{"key":"1068_CR11","unstructured":"National Institute for Health and Care Excellence (NICE): Position statement on use of the EQ-5D-5L valuation set. \n                    https:\/\/www.nice.org.uk\/Media\/Default\/About\/what-we-do\/NICE-guidance\/NICE-technology-appraisal-guidance\/eq5d5l_nice_position_statement.pdf\n                    \n                   (2017). Accessed 20 Nov 2018"},{"key":"1068_CR12","unstructured":"The Agency for Health Technology Assessment and Tariff System (AOTMiT): Health Technology Assessment Guidelines, Version 3.0. \n                    https:\/\/www.aotm.gov.pl\/www\/wp-content\/uploads\/wytyczne_hta\/2016\/20161104_HTA_Guidelines_AOTMiT.pdf\n                    \n                   (2016). Accessed 20 Nov 2018"},{"issue":"11","key":"1068_CR13","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s11136-016-1375-6","volume":"25","author":"F Rencz","year":"2016","unstructured":"Rencz, F., Gul\u00e1csi, L., Drummond, M., et al.: EQ-5D in Central and Eastern Europe: 2000\u20132015. Qual Life Res 25(11), 2693\u20132710 (2016)","journal-title":"Qual Life Res"},{"issue":"12","key":"1068_CR14","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00296-017-3800-8","volume":"37","author":"Z Zrubka","year":"2017","unstructured":"Zrubka, Z., Rencz, F., Z\u00e1vada, J., et al.: EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis. Rheumatol Int 37(12), 1957\u20131977 (2017)","journal-title":"Rheumatol Int"},{"issue":"5","key":"1068_CR15","doi-asserted-by":"publisher","first-page":"860","DOI":"10.5603\/KP.a2018.0033","volume":"76","author":"P Bat\u00f3g","year":"2018","unstructured":"Bat\u00f3g, P., Rencz, F., P\u00e9ntek, M., et al.: EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature. Kardiol Pol 76(5), 860\u2013870 (2018)","journal-title":"Kardiol Pol"},{"issue":"10","key":"1068_CR16","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman, M., Gudex, C., Lloyd, A., et al.: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20(10), 1727\u20131736 (2011)","journal-title":"Qual Life Res"},{"key":"1068_CR17","unstructured":"van Reenen, M., Janssen, B., Oppe, M., Kreimeier, S., Greiner, W.: EQ-5D-Y User Guide, Basic information on how to use the EQ-5D-Y instrument. Version 1.0. \n                    https:\/\/euroqol.org\/wp-content\/uploads\/2016\/09\/EQ-5D-Y_User_Guide_v1.0_2014.pdf\n                    \n                   (2014). Accessed 15 Oct 2018"},{"issue":"5\u20136","key":"1068_CR18","first-page":"1","volume":"69","author":"M P\u00e9ntek","year":"2016","unstructured":"P\u00e9ntek, M., Herczegfalvi, \u00c1., Moln\u00e1r, M.J., et al.: Disease burden of Duchenne muscular dystrophy patients and their caregivers. Ideggyogy Sz 69(5\u20136), 1\u201311 (2016)","journal-title":"Ideggyogy Sz"},{"issue":"Suppl 1","key":"1068_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10198-016-0782-5","volume":"17","author":"M Cavazza","year":"2016","unstructured":"Cavazza, M., Kodra, Y., Armeni, P., et al.: Social\/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe. Eur J Health Econ 17(Suppl 1), 19\u201329 (2016)","journal-title":"Eur J Health Econ"},{"key":"1068_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3233\/JPD-140459","volume":"4","author":"K Horvath","year":"2014","unstructured":"Horvath, K., Aschermann, Z., \u00c1cs, P., et al.: Test-retest validity of Parkinson\u2019s disease sleep scale 2nd version (PDSS-2). J Parkinsons Dis 4, 687\u2013691 (2014)","journal-title":"J Parkinsons Dis"},{"issue":"7\u20138","key":"1068_CR21","first-page":"245","volume":"67","author":"N Kov\u00e1cs","year":"2014","unstructured":"Kov\u00e1cs, N., Aschermann, Z., \u00c1cs, P., et al.: The impact of Levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson\u2019s disease. Ideggyogy 67(7\u20138), 245\u2013250 (2014)","journal-title":"Ideggyogy"},{"key":"1068_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7951840","author":"N Kov\u00e1cs","year":"2016","unstructured":"Kov\u00e1cs, M., Makkos, A., Aschermann, Z., et al.: Impact of sex on the nonmotor symptoms and the health-related quality of life in Parkinson\u2019s disease. Parkinson\u2019s Disease (2016). \n                    https:\/\/doi.org\/10.1155\/2016\/7951840","journal-title":"Parkinson\u2019s Dis"},{"key":"1068_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/936865","author":"G Deli","year":"2015","unstructured":"Deli, G., Bal\u00e1s, I., D\u00f3czi, T., et al.: Deep brain stimulation can preserve working status in Parkinson\u2019s disease. Parkinson\u2019s Disease (2015). \n                    https:\/\/doi.org\/10.1155\/2015\/936865","journal-title":"Parkinson\u2019s Dis"},{"key":"1068_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/158353","author":"E Bosny\u00e1k","year":"2014","unstructured":"Bosny\u00e1k, E., Herceg, M., P\u00e1l, E., et al.: Are branded and generic extended-release Ropinirole formulations equally efficacious? A rater-blinded, switch-over, multicenter study. Parkinson\u2019s Disease (2014).  \n                    https:\/\/doi.org\/10.1155\/2014\/158353","journal-title":"Parkinson\u2019s Dis"},{"issue":"2","key":"1068_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/WNF.0b013e31824687bf","volume":"35","author":"M Herceg","year":"2012","unstructured":"Herceg, M., Nagy, F., P\u00e1l, E., et al.: Pramipexole may be an effective treatment option in essential tremor. Clin Neuropharmacol 35(2), 73\u201376 (2012)","journal-title":"Clin Neuropharmacol"},{"issue":"9\u201310","key":"1068_CR26","first-page":"1","volume":"68","author":"V Brodszky","year":"2015","unstructured":"Brodszky, V., P\u00e9ntek, M., Komoly, S., et al.: Quality of life of patients with non-diabetic peripheral neuropathic pain; results from a cross-sectional survey in general practices in Hungary. Ideggyogy 68(9\u201310), 1\u20136 (2015)","journal-title":"Ideggyogy"},{"issue":"1\u20132","key":"1068_CR27","first-page":"42","volume":"61","author":"P Kliv\u00e9nyi","year":"2008","unstructured":"Kliv\u00e9nyi, P., V\u00e9csei, L.: The use of Stalevo in Hungary An observational study. Ideggyogy Sz 61(1\u20132), 42\u201348 (2008)","journal-title":"Ideggyogy Sz"},{"issue":"7\u20138","key":"1068_CR28","first-page":"249","volume":"65","author":"G Deli","year":"2012","unstructured":"Deli, G., Bal\u00e1s, I., Komoly, S., et al.: Treatment of dystonia by deep brain stimulation: a summary of 40 cases. Ideggyogy Sz 65(7\u20138), 249\u2013260 (2012)","journal-title":"Ideggyogy Sz"},{"issue":"7\u20138","key":"1068_CR29","first-page":"247","volume":"63","author":"M Bokor","year":"2010","unstructured":"Bokor, M., Szentesi, A.: The effect of Stalevo-dosing on quality of life of Parkinsonian patients with wearing-off. Ideggyogy Sz 63(7\u20138), 247\u2013251 (2010)","journal-title":"Ideggyogy Sz"},{"issue":"9\u201310","key":"1068_CR30","first-page":"316","volume":"65","author":"M P\u00e9ntek","year":"2012","unstructured":"P\u00e9ntek, M., Gul\u00e1csi, L., R\u00f3zsa, C., et al.: Health status and costs of ambulatory patients with multiple sclerosis in Hungary. Ideggyogy Sz 65(9\u201310), 316\u2013324 (2012)","journal-title":"Ideggyogy Sz"},{"key":"1068_CR31","unstructured":"Tam\u00e1s, G., Gul\u00e1csi, L., Bereczki, D., et al.: Quality of life and costs in Parkinson\u2019s disease: A cross sectional study in Hungary (2014). \n                    https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0107704\n                    \n                  . Accessed 30 Nov 2018"},{"issue":"7\u20138","key":"1068_CR32","first-page":"251","volume":"66","author":"M P\u00e9ntek","year":"2013","unstructured":"P\u00e9ntek, M., Bereczki, D., Gul\u00e1csi, L., et al.: Survey of adults with epilepsy in Hungary: health related quality of life and costs. Ideggyogy Sz 66(7\u20138), 251\u2013261 (2013)","journal-title":"Ideggyogy Sz"},{"key":"1068_CR33","doi-asserted-by":"crossref","unstructured":"P\u00e9ntek, M., Kobelt, G., Berg, J., Capsa, D., Dal\u00e9n, J., B\u00edr\u00f3, Z., M\u00e1ty\u00e1s, K., Komoly, S.: New insights into the burden and costs of multiple sclerosis in Europe: Results for Hungary. European Multiple Sclerosis Platform. Mult Scler 23(2_suppl), 91\u2013103 (2017)","DOI":"10.1177\/1352458517708142"},{"issue":"3","key":"1068_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5114\/ms.2017.70345","volume":"33","author":"W Brola","year":"2017","unstructured":"Brola, W., Sobolewski, P., Fudala, M., Flaga, S., Jantarski, K.: Multiple sclerosis: patient-reported quality of life in the \u015awi\u0119tokrzyskie Region. Med Stud 33(3), 191\u2013198 (2017)","journal-title":"Med Stud"},{"key":"1068_CR35","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s11136-014-0873-7","volume":"24","author":"D Golicki","year":"2015","unstructured":"Golicki, D., Niewada, M., Karlinska, A., et al.: Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients. Qual Life Res 24, 1555\u20131563 (2015)","journal-title":"Qual Life Res"},{"key":"1068_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11136-014-0834-1","volume":"24","author":"D Golicki","year":"2015","unstructured":"Golicki, D., Niewada, M., Karlinska, A., et al.: Validity of EQ-5D-5L in stroke. Qual Life Res 24, 845\u2013850 (2015)","journal-title":"Qual Life Res"},{"key":"1068_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.advms.2013.07.002","volume":"59","author":"K Mitosek-Szewczyk","year":"2014","unstructured":"Mitosek-Szewczyk, K., Ku\u0142akowska, A., Bartosik-Psujek, H., et al.: Quality of life in Polish patients with multiple sclerosis. Adv Med Sci 59, 34\u201338 (2014)","journal-title":"Adv Med Sci"},{"key":"1068_CR38","first-page":"433","volume":"3","author":"B \u0141abuz-Roszak","year":"2013","unstructured":"\u0141abuz-Roszak, B., Kubicka-B\u0105czyk, K., Pierzcha\u0142a, K., et al.: Quality of life in multiple sclerosis\u2014association with clinical features, fatigue and depressive syndrome. Psychiatr Pol 3, 433\u2013441 (2013)","journal-title":"Psychiatr Pol"},{"issue":"5","key":"1068_CR39","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/00207454.2014.937002","volume":"125","author":"K Pierzchala","year":"2015","unstructured":"Pierzchala, K., Adamczyk-Sowa, M., Dobrakowski, P., et al.: Demographic characteristics of MS patients in Poland\u2019s upper Silesia region. Int J Neurosci 125(5), 344\u2013351 (2015)","journal-title":"Int J Neurosci"},{"issue":"6","key":"1068_CR40","first-page":"32","volume":"63","author":"J Pasek","year":"2009","unstructured":"Pasek, J., Szajkowsk, S., Suszy\u0144ski, K., Wiaderkiewicz, J., Kwiek, S.: The quality of life at patients with the extrapyramidal system diseases after stereotactic surgery and rehabilitation. Ann Acad Med Siles 63(6), 32\u201339 (2009)","journal-title":"Ann Acad Med Siles"},{"issue":"4","key":"1068_CR41","first-page":"631","volume":"64","author":"K Turza\u0144ska","year":"2016","unstructured":"Turza\u0144ska, K., Zaborek, S., Posturzy\u0144ska, A., et al.: Peripheral nerves alcoholization in the spasticity management. Wiad Lek 64(4), 631\u2013636 (2016)","journal-title":"Wiad Lek"},{"issue":"2","key":"1068_CR42","first-page":"81","volume":"6","author":"D Halicka","year":"2017","unstructured":"Halicka, D., Tarasiuk, J., Szczepa\u0144ski, M., Krajewska, A., Ku\u0142akowska, A.: Fatigue syndrome, depression and the quality of life in patients with multiple sclerosis. J Neurol Neurosurg Nurs 6(2), 81\u201387 (2017)","journal-title":"J Neurol Neurosurg Nurs"},{"key":"1068_CR43","doi-asserted-by":"crossref","unstructured":"Selmaj, K., Kobelt, G., Berg, J., Orlewska, E., Capsa, D., Dal\u00e9n, J.: New insights into the burden and costs of multiple sclerosis in Europe: Results for Poland. European Multiple Sclerosis Platform. Mult Scler 23(2_suppl), 130\u201342 (2017)","DOI":"10.1177\/1352458517708666"},{"key":"1068_CR44","first-page":"75","volume":"4","author":"M Prugger","year":"2013","unstructured":"Prugger, M., Berger, T.: Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases. Patient Relat Outcome Meas 4, 75\u201385 (2013)","journal-title":"Patient Relat Outcome Meas"},{"key":"1068_CR45","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00415-009-5389-7","volume":"257","author":"Y Winter","year":"2010","unstructured":"Winter, Y., von Campenhausen, S., Gasser, J., et al.: Social and clinical determinants of quality of life in Parkinson\u2019s disease in Austria: a cohort study. J Neurol 257, 638\u2013645 (2010)","journal-title":"J Neurol"},{"key":"1068_CR46","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1007\/s00115-004-1732-5","volume":"75","author":"U Ganzinger","year":"2004","unstructured":"Ganzinger, U., Badeltz, C., Vass, K., et al.: Krankheitskosten der multiplen Sklerose in \u00d6sterreich. Nervenarzt 75, 1000\u20131006 (2004)","journal-title":"Nervenarzt"},{"key":"1068_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10198-006-0382-x","volume":"7","author":"G Kobelt","year":"2006","unstructured":"Kobelt, G., Berg, J., Lindgren, P., et al.: Costs and quality of life of multiple sclerosis in Austria. Eue J Health Econ 7, 14\u201323 (2006)","journal-title":"Eue J Health Econ"},{"key":"1068_CR48","doi-asserted-by":"crossref","unstructured":"Berger, T., Kobelt, G., Berg, J., Capsa, D., Gannedahl, M.: New insights into the burden and costs of multiple sclerosis in Europe: Results for Austria. European Multiple Sclerosis Platform. Mult Scler 23(2_suppl), 17\u201328 (2017)","DOI":"10.1177\/1352458517708099"},{"key":"1068_CR49","first-page":"28","volume":"15","author":"T Dole\u017eal","year":"2012","unstructured":"Dole\u017eal, T., Vocelka, M., Klime\u0161, J.: Clinical effectiveness of 8% Capsaicin Dermal patch in neuropathic pain\u2014non-interventional real-life clinical study in Czech Republic. Bolest 15, 28\u201332 (2012)","journal-title":"Bolest"},{"issue":"2","key":"1068_CR50","first-page":"61","volume":"18","author":"P Otruba","year":"2015","unstructured":"Otruba, P.: Neuritogen and diabetic neuropathic pain. Diabetologie 18(2), 61\u201368 (2015)","journal-title":"Diabetologie"},{"key":"1068_CR51","doi-asserted-by":"crossref","unstructured":"Havrdova, E., Kobelt, G., Berg, J., Capsa, D., Gannedahl, M., Dole\u017eal, T.: New insights into the burden and costs of multiple sclerosis in Europe: Results for Czech Republic. European Multiple Sclerosis Platform. Mult Scler 23(2_suppl), 41\u201352 (2017)","DOI":"10.1177\/1352458517708117"},{"key":"1068_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.vhri.2014.07.001","volume":"4","author":"V Prevolnik Rupel","year":"2014","unstructured":"Prevolnik Rupel, V., Ogorevc, M.: Use of the EQ-5D instrument and value scale in comparing health states of patients in four health care programs among health care providers. Value Health Reg Issues 4, 95\u201399 (2014)","journal-title":"Value Health Reg Issues"},{"key":"1068_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.clineuro.2015.08.023","volume":"139","author":"K Pavsic","year":"2015","unstructured":"Pavsic, K., Pelicon, K., Horvat Ledinek, A., Sega, S.: Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients. Clin Neurol Neurosurg 139, 35\u201340 (2015)","journal-title":"Clin Neurol Neurosurg"},{"key":"1068_CR54","unstructured":"van Reenen, M., Oppe, M.: EQ-5D-3L User Guide: Basic information on how to use the EQ-5D-3L instrument. Version 5.1. \n                    https:\/\/euroqol.org\/wp-content\/uploads\/2016\/09\/EQ-5D-3L_UserGuide_2015.pdf\n                    \n                   (2015). Accessed 16 Oct 2018"},{"key":"1068_CR55","doi-asserted-by":"crossref","unstructured":"Verstraete, J., Ramma, L., Jelsma, J.: Influence of the child\u2019s perceived general health on the primary caregiver\u2019s health status. Health and Quality of Life Outcomes 16(1) (2018). \n                    10.1186\/s12955-018-0840-z","DOI":"10.1186\/s12955-018-0840-z"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-019-01068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10198-019-01068-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-019-01068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T19:17:36Z","timestamp":1589483856000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10198-019-01068-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,16]]},"references-count":55,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1068"],"URL":"https:\/\/doi.org\/10.1007\/s10198-019-01068-9","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,16]]},"assertion":[{"value":"9 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DG and VPR are members of the EuroQol Group, a not-for-profit organization that develops and distributes instruments that assess and value health. Other authors reported no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}